ArticleJournal of the National Cancer Center2024

Dynamic bTMB combined with residual ctDNA improves survival prediction in locally advanced NSCLC patients with chemoradiotherapy and consolidation immunotherapy.

Yu Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.